The Air Liquide group company is accelerating its investments in biotechnologies. Seppic has opened a laboratory dedicated to fermentation at the group’s Innovation Campus Delaware, where Seppic’s American Customer Technical Service Center has been based since 2007.
Fermentation is a process historically used to produce and preserve food. Applied to the cosmetics and health markets, this technology enables the production of biobased ingredients with limited impact on the environment and biodiversity, while minimizing impact on land use.
“With new equipment and extensive know-how, the aim of this laboratory will be to develop new ingredients that combine efficacy with a response to societal challenges in the cosmetics and health fields, in line with the company’s approach to committed innovation,” said the company in a statement.
With this choice of location, Seppic aims to benefit from strong synergies with Air Liquide Group R&D activities on the Campus, as well as with the dynamic American Research ecosystem in the field of biotechnologies.
“Following the opening in 2024 of new Research facilities at our Castres site in France, Seppic continues to invest in the future with this laboratory in the United States. It will enable us to continue innovating for the performance of our ingredients by addressing the needs of our markets,” said Hannes Moeller, Chief Executive Officer of Seppic.
